合成和生物评价作为潜在的结肠癌原体的乙基诺米辛类似物
Keita Kojima1, Hiroaki Konishi2, Kyoka Momosaki1
1Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan.
Scientific reports
|April 1, 2024
概括
新型埃基诺米辛类似物在结肠癌治疗中表现有前途. 模拟物3在体内有效抑制癌症生长,毒性较低,这表明它作为一种新的化疗剂的潜力.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 结肠直肠癌是癌症死亡的主要原因,需要新的治疗策略.
- 乙胺,一种天然的循环,对各种细胞系表现出强大的抗癌活性.
研究的目的:
- 合成和评估用于结肠癌治疗的新型埃基诺米辛类型.
- 研究这些类似物的作用机制和体内疗效.
主要方法:
- 合成埃基诺米辛类似物.
- 在实验室中评估抑制HIF-1α介导的转录.
- 转录组分析以确定细胞效应.
- 使用老鼠异种移植模型进行体内评估.
主要成果:
- 模拟器3和模拟器1抑制了HIF-1α介导的转录.
- 转录组分析显示,细胞循环调节是模拟3的一个关键目标.
- 同类型3在体内表现出优越的疗效,与无显著毒性埃基诺米辛相比.
结论:
- 模拟3是一种有前途的新药,用于结肠癌治疗.
- 它的低剂量疗效和有利的安全性概况需要进一步研究.
相关概念视频
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...